Why Trace Opioid Detection Is Different From a Verified Adulterated Dose
Short answer: Detecting an unexpected opioid at trace level does not, by itself, establish that a product contained an active adulterating dose. In a British Columbia drug-checking study, 189 of 8,889 samples not expected to include fentanyl had an unexpected opioid, and 61.4% of those detections were at trace concentration. The authors considered contamination, misrepresented samples and adulteration as different possible explanations.
What was actually submitted?
Wallace and colleagues examined drug-checking submissions from 2021–2023. The 8,889-sample subset was defined by what the submitter expected the sample to contain. That expectation is a description, not a chemical test. The laboratory’s finding refers to the submitted material, not a person’s blood or an observed dose.
Why distinguish trace from above-trace findings?
Most unexpected-opioid detections in the relevant subset were trace-level. The authors report that the combination of the expected drug with an unexpected opioid above trace was the least common scenario, below 1%. This distinction helps prevent the statement “opioid detected” from becoming an unsupported claim that a particular person received a pharmacologically important dose.
A trace may have several origins, and the study does not identify a single origin for every positive sample. Likewise, a sample that lacks its expected drug raises a different interpretation problem from a sample that contains both the expected drug and an unexpected opioid.
What would an individual case require?
Identify the tested product or biological specimen, analytical method, concentrations, limits and chain of custody. Separate detected compounds from reported product labels, exposure, dose and clinical effect. The British Columbia study informs how mixed sample patterns can be read; it cannot establish what was in an untested packet or why one person experienced an overdose.
Scientific source
Wallace B, Shkolnikov I, Kielty C, et al. Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply. Harm Reduction Journal. 2025;22:28. doi:10.1186/s12954-025-01189-w. Based on the supplied full paper.



